DAILY EQUITY REPORT 10TH APRIL 2014
Daily Equity Report Phone: 0731-6662200 E-mail: info@capitalstars.com
INDIAN MARKET
INDIAN FACE
INDICES
CLOSE
PREVIOUS
SENSEX
22702.34
22343.45
NIFTY
6796.20
6695.05
INDIAN EQUITY BENCHMARK ended by trading at the highs of the day, bolstered by strength on the banking counters. DLF rose 1.96% after the company issued a clarification with regard
ASIAN MARKET INDICES
CLOSE
PREVIOUS
NIKKEI
14299.69
14606.88
HANG SENG
22843.17
22596.97
KOSPI
1998.95
1993.03
to penalty charged against it by the Competition Commission of India.
Further, Reliance Power rose 2.16% after the company said that boiler lightup has been achieved for its fourth 660
SECTORIAL INDICES
megawatt unit at the 3,960 megawatt Sasan Ultra Mega Power
INDICES
CLOSE
CHANGE (%)
CNX 100
6691.90
1.53
S&P CNX 500
5315.25
1.55
CNX MIDCAP
8751.15
1.56
CNX 200
3405.65
1.53
BANK NIFTY
12937.40
3.45
Plant.
Hindalco Industries advanced 4.23% after Alcoa Inc reported quarterly earnings that beat analysts' expectations on Tuesday.
GLOBAL FACE
TOP GAINERS SCRIPT
CLOSE
CHANGE (%)
SUNPHARMA
628.00
6.78
BANKBARODA
790.30
5.32
AXIS BANK
1486.65
4.54
TATAMOTORS
422.20
4.50
Asian stock markets traded mixed, after the morning session with the focus on global tech stocks on concerns U.S. equities are due for a correction.
European stocks market higher, as investors eyed the Federal Reserve's upcoming policy statement due later in the day and as
TOP LOSERS
comments by the International Monetary Fund on Tuesday
SCRIPT
CLOSE
CHANGE (%)
TECHM
1739.00
-3.01
HCL TECH
1377.70
-2.04
INFY
3250.45
-1.30
participants were awaiting the Federal Reserve's monthly
ONGC
322.00
-1.11
policy statement later in the day.
www.capitalstars.com
continued to support.
U.S. stocks markets pointed to a higher open as market
*Equity *Derivatives *Commodity *Research
CAPITAL STARS FINANCIAL RESEARCH PRIVATE LIMITED PLOT NO. 12, SCHEME NO. 78, PART II VIJAYNAGAR INDORE 452001 (MP) OFFICE: - +91 731 6662200, MOB: +91 92000 99927, FAX: +91 731 6662222, EMAIL: info@capitalstars.com
Daily Equity Report
r
MARKET MOVERS UPSIDE SCRIPT
CLOSE
RELIANCE
962.15
CHANGE (%) 1.9
ITC
347.95
0.7
COAL INDIA
288.15
1.5
HDFC BANK
741.85
2.3
Capital stars Market Analysis & Research Team
NIFTY SPOT TREND BULLISH S3 6562
S2
S1
6666
6731
PIVOT POINTS P
6770 SUPPORT S1-6700 S2-6670
NIFTY
STRATEGY BUY ON DIPS R1
R2
R3
6834
6873
6977
RESISTANCE R1-6830 R2-6870
MARKET MOVERS DOWNSIDE SCRIPT
CLOSE
TCS
2140.40
CHANGE (%) [0.6]
ONGC
322.45
[1.0]
INFOSYS
3254.55
[1.2]
WIPRO
554.45
[0.4]
FII & DII ACTIVITY INSTITUTION
NET BUY (CR.)
NET SELL (CR)
FII
3591.96
2888.25
DII
689.84
1771.20
NSE TOTALS INDICES
ADVANCES
DECLINES
NIFTY
39
11
BANK NIFTY
12
0
www.capitalstars.com
BANK NIFTY FUTURE TREND BULLISH S3 12059
S2
12481
BANK NIFTY
STRATEGY BUY ON DIPS
PIVOT POINTS P R1 R2 R3 12903 12758 13180 13325 13747 SUPPORT RESISTANCE S1-12400 R1-13230 S2-12150 R2-13350 S1
*Equity *Derivatives *Commodity *Research
CAPITAL STARS FINANCIAL RESEARCH PRIVATE LIMITED PLOT NO. 12, SCHEME NO. 78, PART II VIJAYNAGAR INDORE 452001 (MP) OFFICE: - +91 731 6662200, MOB: +91 92000 99927, FAX: +91 731 6662222, EMAIL: info@capitalstars.com
Daily Equity Report r Capital stars Market Analysis & Research Team
MARKET TALKS
position during 2013-14 even while operating in a difficult business
JSW Steel gets nod to use CIL rail infra for Rohne mine
environment.
Coal India has agreed to let JSW Steel use rail infrastructure of its
RIL refuses to budge on gas price hike
arm CCL so that the private firm is able to mine and transport coal from a Jharkhand block allocated to it for captive use. The nod
Reliance Industries has said it is not bound by any agreement to
follows a meeting of a high-level panel on clearing bottlenecks
supply gas from its KG-D6 at $4.2/mmbtu even in the interim. Last
impeding steel projects.
week, RIL had agreed to supply natural gas to fertiliser companies at $4.2/mmbtu till a new agreement was reached between RIL and
Oil India raises overseas bonds
$1
billion
16 fertiliser companies.
via
Oil India became the first Indian company to sell $1 billion worth of debt in its debut US dollar bond sale programme. The issue is in a
Lupin gets FDA approval for Generic Actos
dual tranche of $500 million each. While $500-million, five-year money has been priced at US treasury plus 222.5 bps, the 10-year
Lupin Ltd has received final approval for its Pioglitazone Tablets
money of the same size has been priced at treasury plus 272.5 bps.
USP, 15 mg, 30 mg, and 45 mg from USFDA to market a generic version of Takeda Pharmaceuticals USA, Inc.’s (Takeda) Actos Tablets, 15 mg, 30 mg, and 45 mg. Lupin Pharmaceuticals Inc.,
BHEL retains its leadership position in a difficult market
the company’s US subsidiary would commence marketing the product shortly.
Bharat Heavy Electricals Limited has retained its market leadership
DISCLAIMER The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Use of this report in no way constitutes a client/advisor relationship, all information we communicate to you (the subscriber) either through our Web site or other forms of communications, are purely for informational purposes only. We recommend seeking individual investment advice before making any investment, for you are assuming sole liability for your investments. Capital Stars will in no way have discretionary authority over your trading or investment accounts. All rights reserved. www.capitalstars.com
*Equity *Derivatives *Commodity *Research
CAPITAL STARS FINANCIAL RESEARCH PRIVATE LIMITED PLOT NO. 12, SCHEME NO. 78, PART II VIJAYNAGAR INDORE 452001 (MP) OFFICE: - +91 731 6662200, MOB: +91 92000 99927, FAX: +91 731 6662222, EMAIL: info@capitalstars.com